Stock Ratings / Health Care / GILD / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Gilead Sciences Inc. (GILD) 12-Month Stock Forecast & Price Target Cone

$165.61 +4.03% NASDAQ • Public Delayed / 60s Snapshot

Gilead Sciences Inc. (GILD) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (68/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+227.5% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D • SELL / AVOID Cap $205.35B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw C · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+4.5% Base Target

WHALE OPTIONS TUG-OF-WAR:58% Call Buyers ($21.4M)

42% PutsMax Pain: $162.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your GILD Position Size: $10,000

Shares at $165.61: 60.4 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $134.99

$8,151

$-1,849 (-18.5%)

12M Consensus BaseTarget $173.06

$10,450

+$450 (+4.5%)

12M Bull Case BreakoutTarget $204.21

$12,331

+$2,331 (+23.3%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$180	74%	A
Goldman SachsSector Coverage Lead	BUY	$192	69%	B
JP MorganUS Large-Cap Research	HOLD	$154	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring GILD)

✓Live walkthrough of GILD's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

GILD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +30.45%▲ RESISTANCE BREAKOUT

2026-10-30O $170.3H $175.7L $169.0C $170.7VOL 11.43M

RES: $167.8SUP: $142.2SMA50: $150.9SMA200: $139.9

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

GILD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 GILD Butterfly Map → + Track GILD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

17.8%/yr Implied 5Y Growth

vs. +2.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on GILD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for GILD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for GILD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

GILD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is GILD's 12-month stock price target?

Gilead Sciences Inc. (GILD) carries a 12-month consensus base price target of $173.06 (+4.5% from $165.61), with a bull-case target of $204.21 and a bear-case floor of $134.99.

Is GILD stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates GILD D (Sell — SELL) with an RQD Confidence score of 68/100.

Direct Sub-Reports: GILD RQD Cockpit GILD 12M Forecast GILD Earnings & Move GILD Dividends & DRIP GILD Insiders & 13F GILD Whale Options GILD Profit Sankey GILD News & Why